Abiopharma

🔍 Jampol Thad (Executive)

Company: Intapp, Inc. (INTA)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 32,058 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 944,965.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,257 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 948,222.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,974 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 950,196.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 15,000 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 965,196.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 26,611 shares of Common Stock at $40.09 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 938,585.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 34,972.00 | Footnotes: F4
• Acquired 46,800 shares of Restricted Share Units (Derivative)
  Date: 2026-08-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 46,800.00 | transaction_form_type: 4 | Footnotes: F5, F5, F6, F6
• Sold 3,257 shares of Restricted Share Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,044.00 | transaction_form_type: 4 | Footnotes: F7, F2, F8, F8
• Sold 1,974 shares of Restricted Share Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,804.00 | transaction_form_type: 4 | Footnotes: F7, F2, F9, F9
• Sold 15,000 shares of Restricted Share Units (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 90,000.00 | transaction_form_type: 4 | Footnotes: F7, F2, F10, F10

Footnotes:

• F1: The shares of Intapp, Inc.'s (the "Issuer") common stock reported in this Form 4 represent shares earned, as certified by the audit committee of the board of directors of the Issuer on August 19, 2026, based on the level of achievement of the applicable performance conditions over the applicable performance period, in respect of performance share units granted pursuant to the Intapp, Inc. 2021 Omnibus Incentive Plan. The earned shares of Issuer common stock reported in this Form 4 are subject to service-based vesting requirements that lapsed on August 20, 2026.
• F2: The reported transaction involved a restricted share unit ("RSU") vesting on August 20, 2026.
• F3: Shares of Intapp, Inc. common stock withheld for taxes upon the vesting of performance share units and RSUs granted pursuant to the Intapp, Inc. 2021 Omnibus Incentive Plan.
• F4: Shares held by the reporting person's spouse. The reporting person disclaims beneficial ownership of the securities owned by his spouse, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F5: The reported transaction involved the reporting person's receipt of a grant of RSUs under the Intapp, Inc. 2021 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Intapp, Inc. common stock.
• F6: The RSUs vest, subject to continued employment, as to 8.33% of the shares on November 20, 2026, and in 11 equal quarterly installments thereafter.
• F7: Each RSU represents a contingent right to receive one share of Intapp, Inc. common stock.
• F8: The RSUs have vested and will vest, subject to continued employment, as to 8.33% of the shares on November 20, 2024, and in 11 equal quarterly installments thereafter.
• F9: The RSUs have vested and will vest, subject to continued employment, as to 8.33% of the shares on November 20, 2025, and in 11 equal quarterly installments thereafter.
• F10: The RSUs have vested and will vest, subject to continued employment, as to 12.5% of the shares on May 20, 2026, and in seven equal quarterly installments thereafter.